News
TipRanks on MSN4h
Sarepta price target raised to $17 from $10 at BofA
BofA raised the firm’s price target on Sarepta (SRPT) to $17 from $10 and keeps an Underperform rating on the shares. The firm surveyed 15 ...
Capricor Therapeutics met with the FDA last week for a type A meeting, during which CEO Linda Marbán aimed to explain to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback